Attached files

file filename
10-K/A - FORM 10-K AMENDMENT NO. 1 - Chelsea Therapeutics International, Ltd.d10ka.htm
EX-31.1 - SECTION 302 CEO CERTIFICATION - Chelsea Therapeutics International, Ltd.dex311.htm
EX-31.2 - SECTION 302 CFO CERTIFICATION - Chelsea Therapeutics International, Ltd.dex312.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Chelsea Therapeutics International, Ltd.dex231.htm
EX-32.1 - SECTION 906 CEO CERTIFICATION - Chelsea Therapeutics International, Ltd.dex321.htm
EX-32.2 - SECTION 906 CFO CERTIFICATION - Chelsea Therapeutics International, Ltd.dex322.htm

Exhibit 23.2

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the registration statements on Forms S-3 (Nos. 333-132330, 333-141964 and 333-171628) and Forms S-8 (Nos. 333-137782, 333-144061, 333-160256 and 333-171627) of our report dated March 10, 2008 relating to the consolidated financial statements of Chelsea Therapeutics International, Ltd. and Subsidiary included in this Annual Report on Form 10-K/A of Chelsea Therapeutics International, Ltd. for the year ended December 31, 2010.

/s/    J.H. Cohn LLP

Roseland, New Jersey

April 7, 2011